| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PODN | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | AKAP4 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | C11orf96 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-08 |
| mRNA | TAT | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | SEL1L2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | GSTA3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | RD3L | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | SYN2 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | CYB561 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
